Pfizer's Own Study Confirms Paxlovid Sucks A Pfizer-funded, peer-reviewed paper authored by Pfizer scientists reveals that the company's antiviral...
World’s top intensive care body advises against remdesivir for sickest Covid patients
How Effective Will Lilly’s Bamlanivimab be in the Battle Against Covid-19?
A CRISPR Approach to Genetic Medicine
How COVID-19 accelerated DoorDash’s business
Euro Rallies on Upbeat Sentiment and Mixed Euro Area Macro Prints
3 "Strong Buy" Dividend Stocks Yielding at Least 10%
NYC Prepares To Close Schools, Puerto Rico Orders National Guard To Help Enforce New COVID-19 Curfew: Live Updates
Justice Alito Slammed By Left After Questioning Constitutionality Of COVID Crackdowns
Dissecting the immune characteristics of severe COVID-19 responses
Antidepressant may prevent severe COVID-19, trial suggests
Indian Rupee Rises As Trade, Sliding COVID-19 Cases Support EM Currency
Disney loses $2.8 billion amid pandemic but improves forecasts
Teacher motivation is vital – and COVID-19 may be hurting it
Four climate strategies that could reach across partisan divides
Coronavirus is no longer seen as high risk by many – and that’s undermining control measures